Agape Atp CORP

Agape ATP Corporation announced it has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market.

Agape ATP Corporation will implement a 1-for-50 reverse stock split effective February 9, 2026, to adjust its common stock trading on Nasdaq.

Agape ATP Corporation received a delisting notice from Nasdaq due to its failure to meet minimum bid price requirements and low-priced stock rules.

Agape ATP Corporation's stockholders approved a potential $300 million share issuance, a reverse stock split, and a significant increase in authorized shares at its Annual Meeting.

Agape ATP Corporation received a Nasdaq notice for failing to meet the minimum $1 bid price requirement, initiating a 180-day compliance period.

Agape ATP Corporation issued a statement addressing recent stock price volatility, reaffirming its strategic outlook and ongoing business operations.

Agape ATP Corporation reported a decrease in revenue for the first quarter of 2026, primarily driven by a strategic shift away from its network marketing business.

Agape ATP Corporation reported increased net losses for Q3 and the nine months ended September 30, 2025, despite revenue growth driven by new segments, while facing significant going concern doubts and internal control weaknesses.

Agape ATP Corporation reported a wider net loss for the second quarter and first half of 2025, despite revenue growth driven by new green energy and skincare segments, as it grapples with declining gross margins and significant internal control weaknesses.

Agape ATP Corporation's Q1 2025 revenue decreased by 9.3% year-over-year, driven by a strategic shift in focus and a decline in overseas customer revenue.

Agape ATP Corporation's Q3 2024 results show a decrease in overall revenue, primarily due to a decline in network marketing, while experiencing growth in complementary health therapies.

Agape ATP Corporation's Q2 2024 results show a shift in revenue streams with a decline in network marketing and growth in complementary health therapies, alongside increased operating expenses.

Agape ATP Corporation announced its fiscal year 2025 results, showing a 15.2% increase in revenue to $1.52 million, driven by growth in wellness and green energy segments, despite a net loss.

Agape ATP Corporation's 2024 10-K filing reveals a revenue decrease, strategic business shifts, and identified material weaknesses in internal control over financial reporting.

Agape ATP Corporation's 2023 annual report reveals a decrease in revenue and a net loss, alongside identified material weaknesses in internal controls.

Agape ATP Corporation will hold its Annual Meeting on January 30, 2026, seeking shareholder approval for a significant capital raise, a reverse stock split, and an increase in authorized shares to support future growth and strategic initiatives.

Agape ATP Corporation is holding a special meeting to seek stockholder approval for increasing authorized shares and issuing shares that could result in a change of control.

Agape ATP Corporation amends its definitive proxy statement to revise disclosures on the age of director nominees for the upcoming annual meeting.

Agape ATP Corporation announces its Annual Meeting of Stockholders to be held on June 28, 2024, to elect five directors and conduct other business.

Agape ATP Corporation has filed an amendment to its S-1 registration statement to offer units consisting of common stock and warrants, aiming to raise capital for growth and market expansion.

Agape ATP Corporation has filed a registration statement for a public offering of units, each consisting of common stock and a warrant.

Agape ATP Corporation files Amendment No. 1 to its Form S-1 registration statement primarily to include Exhibit 23.2, with minor revisions to the cover page and Part II.

Agape ATP Corporation has filed a registration statement for the resale of up to 46 million shares of common stock by selling stockholders, following a recent private placement.

Jane Street Group, LLC, along with its affiliates Jane Street Capital, LLC and Jane Street Global Trading, LLC, has reported beneficial ownership of 5.0% of Agape ATP Corp's common stock.

Lesser Panda Ltd, controlled by Qingshan Tang, has disclosed a significant passive ownership stake of 7.36% in Agape ATP Corp, acquired through a recent subscription agreement.

Vanguard Development Holdings Limited and its director, Teo Jen Jiang, have disclosed a 6.04% beneficial ownership stake in Agape ATP Corp, acquired through a subscription agreement.

Oceanic Equity Partner Limited, controlled by Tan Swee Li, has disclosed a 6.06% beneficial ownership stake in Agape ATP Corp, acquiring 3,031,400 shares through a subscription agreement.

Nexus Investments Group Limited and its director Chew Kok Soon have disclosed a 6.07% beneficial ownership stake in Agape ATP Corp, acquired through a subscription agreement.

Global Fartech Ltd and its director Mingming Chu have disclosed a beneficial ownership of 6.9% in Agape ATP Corp, totaling 3,450,000 common shares, acquired via a subscription agreement.